ARKG is trading 3.01% lower as firmer Treasury yields pressure growth-oriented healthcare and genomics stocks.

  • The S&P 500, Nasdaq Composite, and Dow Jones are also lower on September 23, 2026.
  • Upcoming U.S. flash PMIs and Federal Reserve Vice Chair Michael Barr’s remarks are keeping investors defensive.
  • No dominant ARKG holding-specific catalyst is identified; macro conditions are the clearest explanation.